Overview
Psychostimulant dependence, particularly episodic dependence, refers to a condition characterized by recurrent episodes of compulsive drug use despite adverse consequences. This condition primarily affects individuals who misuse stimulants such as amphetamines and methylphenidate, often driven by the drugs' potent reinforcing effects mediated through dopaminergic pathways. Clinicians encounter this issue frequently in settings dealing with substance abuse disorders, necessitating a nuanced understanding for effective management and prevention of relapse. Recognizing and addressing episodic dependence is crucial for tailoring interventions that can mitigate the risk of repeated episodes and associated health complications. 123456789101112131415161718192021222324252627282930Pathophysiology
The pathophysiology of psychostimulant dependence involves complex neurobiological mechanisms centered around neurotransmitter systems, particularly dopamine and glutamate. Psychostimulants like amphetamines and methylphenidate primarily exert their effects by blocking the dopamine transporter (DAT), leading to increased dopamine levels in the synaptic cleft and activation of mesolimbic pathways, including the nucleus accumbens (NAc) and ventral tegmental area (VTA). This heightened dopaminergic activity reinforces drug-seeking behavior and contributes to the development of dependence. 123456789101112131415161718192021222324252627282930Glutamatergic neurotransmission also plays a critical role, with alterations in glutamatergic signaling within the mesocorticolimbic pathway implicated in the neuroplastic changes that underlie addictive behaviors. Specifically, dysregulation of metabotropic glutamate receptors (mGluRs), particularly Group III receptors like mGlu8, can influence the acquisition and expression of conditioned reward behaviors, potentially exacerbating dependence episodes. 123456789101112131415161718192021222324252627282930
Epidemiology
Epidemiological data on episodic psychostimulant dependence are limited but suggest a significant burden, particularly among younger populations and those with a history of mental health disorders. Incidence rates can vary widely based on geographic location and accessibility to illicit substances. Prevalence studies often highlight higher rates in urban areas and among individuals with comorbid psychiatric conditions such as ADHD or mood disorders. Trends indicate an increasing recognition of episodic patterns, possibly due to improved diagnostic criteria and heightened awareness. 123456789101112131415161718192021222324252627282930Clinical Presentation
Patients with episodic psychostimulant dependence typically present with a cyclical pattern of drug use characterized by periods of intense craving, escalating use, and subsequent withdrawal symptoms such as fatigue, depression, and cognitive impairments. Atypical presentations may include subtle mood disturbances or cognitive deficits that precede overt drug-seeking behavior. Red-flag features include sudden changes in social behavior, academic or occupational decline, and physical signs like dilated pupils or hyperactivity. 123456789101112131415161718192021222324252627282930Diagnosis
Diagnosing episodic psychostimulant dependence involves a comprehensive clinical assessment including a detailed history of substance use, psychiatric evaluation, and sometimes neurocognitive testing. Specific criteria include:Required Tests:
(Evidence: Moderate) 123456789101112131415161718192021222324252627282930
Differential Diagnosis
(Evidence: Moderate) 123456789101112131415161718192021222324252627282930
Management
First-Line Treatment
Specific Interventions:
(Evidence: Strong) 123456789101112131415161718192021222324252627282930
Second-Line Treatment
Specific Interventions:
(Evidence: Moderate) 123456789101112131415161718192021222324252627282930
Refractory Cases
Specific Interventions:
(Evidence: Weak) 123456789101112131415161718192021222324252627282930
Complications
Management Triggers:
(Evidence: Moderate) 123456789101112131415161718192021222324252627282930
Prognosis & Follow-Up
The prognosis for episodic psychostimulant dependence varies widely depending on the individual's engagement in treatment and the presence of comorbid conditions. Positive prognostic indicators include early intervention, strong social support, and absence of severe psychiatric comorbidities. Recommended follow-up intervals typically involve:(Evidence: Moderate) 123456789101112131415161718192021222324252627282930
Special Populations
(Evidence: Moderate) 123456789101112131415161718192021222324252627282930
Key Recommendations
References
Showing 100 priority papers (full text preferred, most recent first) of 124 indexed.
1 Kahvandi N, Ebrahimi Z, Karimi SA, Shahidi S, Salehi I, Naderishahab M et al.. The effect of the mGlu8 receptor agonist, (S)-3,4-DCPG on acquisition and expression of morphine-induced conditioned place preference in male rats. Behavioral and brain functions : BBF 2021. link 2 Zanettini C, Scaglione A, Keighron JD, Giancola JB, Lin SC, Newman AH et al.. Pharmacological classification of centrally acting drugs using EEG in freely moving rats: an old tool to identify new atypical dopamine uptake inhibitors. Neuropharmacology 2019. link 3 Jing Li J, Szkudlarek H, Renard J, Hudson R, Rushlow W, Laviolette SR. Fear Memory Recall Potentiates Opiate Reward Sensitivity through Dissociable Dopamine D1 versus D4 Receptor-Dependent Memory Mechanisms in the Prefrontal Cortex. The Journal of neuroscience : the official journal of the Society for Neuroscience 2018. link 4 Bagdas D, Muldoon PP, AlSharari S, Carroll FI, Negus SS, Damaj MI. Expression and pharmacological modulation of visceral pain-induced conditioned place aversion in mice. Neuropharmacology 2016. link 5 Li Y, Zhou Y, Jiang J, Wang X, Fu Y, Gong T et al.. Mechanism of brain targeting by dexibuprofen prodrugs modified with ethanolamine-related structures. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2015. link 6 Clissold KA, Pratt WE. The effects of nucleus accumbens μ-opioid and adenosine 2A receptor stimulation and blockade on instrumental learning. Behavioural brain research 2014. link 7 Tanno T, Maguire DR, Henson C, France CP. Effects of amphetamine and methylphenidate on delay discounting in rats: interactions with order of delay presentation. Psychopharmacology 2014. link 8 Shen H, Kalivas PW. Reduced LTP and LTD in prefrontal cortex synapses in the nucleus accumbens after heroin self-administration. The international journal of neuropsychopharmacology 2013. link 9 Baudonnat M, Guillou JL, Husson M, Vandesquille M, Corio M, Decorte L et al.. Disrupting effect of drug-induced reward on spatial but not cue-guided learning: implication of the striatal protein kinase A/cAMP response element-binding protein pathway. The Journal of neuroscience : the official journal of the Society for Neuroscience 2011. link 10 Bosse KE, Jutkiewicz EM, Gnegy ME, Traynor JR. The selective delta opioid agonist SNC80 enhances amphetamine-mediated efflux of dopamine from rat striatum. Neuropharmacology 2008. link 11 Blaiss CA, Janak PH. Post-training and post-reactivation administration of amphetamine enhances morphine conditioned place preference. Behavioural brain research 2006. link 12 Ford CP, Mark GP, Williams JT. Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location. The Journal of neuroscience : the official journal of the Society for Neuroscience 2006. link 13 Pitts RC, McKinney AP. Effects of methylphenidate and morphine on delay-discount functions obtained within sessions. Journal of the experimental analysis of behavior 2005. link 14 Cox EH, Kuipers JA, Danhof M. Pharmacokinetic-pharmacodynamic modelling of the EEG effect of alfentanil in rats: assessment of rapid functional adaptation. British journal of pharmacology 1998. link 15 de Lange EC, Bouw MR, Mandema JW, Danhof M, de Boer AG, Breimer DD. Application of intracerebral microdialysis to study regional distribution kinetics of drugs in rat brain. British journal of pharmacology 1995. link 16 Patsalos PN, Abed WT, Alavijeh MS, O'Connell MT. The use of microdialysis for the study of drug kinetics: some methodological considerations illustrated with antipyrine in rat frontal cortex. British journal of pharmacology 1995. link 17 Mita S, Ono S. A Comparison of Regional Decisions for Doses and Administrations of New Drugs: Concordance, Discordance, and Dependencies. Clinical pharmacology and therapeutics 2026. link 18 Amohashemi E, Reisi P, Alaei H. The role of NMDA glutamate receptors in the lateral habenula on morphine-induced conditioned place preference in rats. Synapse (New York, N.Y.) 2023. link 19 Wang X, Zhang S, Wang C, Huang Y, Wu H, Zhao G et al.. Real-time evaluation of the independent analgesic efficacy of dexmedetomidine. BMC anesthesiology 2023. link 20 Samimi AS, Molaei MM, Azari O, Rezaei MA, Hashemian A. Comparative Evaluation of the Sedative and Analgesic Effects of Caudal Epidural Administration of Lidocaine Alone or in Combination With Xylazine, Detomidine, Medetomidine, and Dexmedetomidine in Mediterranean Miniature Donkeys. Journal of equine veterinary science 2022. link 21 Saberian H, Asgari Taei A, Torkaman-Boutorabi A, Riahi E, Aminyavari S, Naghizadeh A et al.. Effect of histone acetylation on maintenance and reinstatement of morphine-induced conditioned place preference and ΔFosB expression in the nucleus accumbens and prefrontal cortex of male rats. Behavioural brain research 2021. link 22 Hanafi AL, Reed RA, Trenholme HN, Sakai DM, Ryan CA, Barletta M et al.. Pharmacokinetics and pharmacodynamics of meperidine after intramuscular and subcutaneous administration in horses. Veterinary surgery : VS 2021. link 23 ElMeshad AN, Abdel-Haleem KM, Abdel Gawad NA, El-Nabarawi MA, Sheta NM. Core in Cup Ethylmorphine Hydrochloride Tablet for Dual Fast and Sustained Pain Relief: Formulation, Characterization, and Pharmacokinetic Study. AAPS PharmSciTech 2020. link 24 Cai S, Zheng J, Meng Q, Chai J, Ma R, Wang Y et al.. Investigation of the Minimum Local Analgesic Concentration of Epidural Sufentanil Combined With Ropivacaine for Labor Analgesia. Clinical therapeutics 2020. link 25 Liu GX, Wei JY, Liu M, Shi WJ, Song LH, Li S et al.. Epigenetic upregulation of hippocampal CXCL12 contributes to context spatial memory-associated morphine conditioning. Brain, behavior, and immunity 2020. link 26 Gozalo-Marcilla M, Luna SPL, Moreira da Silva R, Crosignani N, Lopes NP, Taylor PM et al.. Characterisation of the in vivo interactions between detomidine and methadone in horses: Pharmacokinetic and pharmacodynamic modelling. Equine veterinary journal 2019. link 27 Forsyth A, McMillan R, Campbell D, Malpas G, Maxwell E, Sleigh J et al.. Comparison of local spectral modulation, and temporal correlation, of simultaneously recorded EEG/fMRI signals during ketamine and midazolam sedation. Psychopharmacology 2018. link 28 Marzok MA, El-Khodery SA. Comparative antinociceptive and sedative effects of epidural romifidine and detomidine in buffalo (. The Veterinary record 2017. link 29 Perreau-Lenz S, Hoelters LS, Leixner S, Sanchis-Segura C, Hansson A, Bilbao A et al.. mPer1 promotes morphine-induced locomotor sensitization and conditioned place preference via histone deacetylase activity. Psychopharmacology 2017. link 30 Hu SP, Zhao JJ, Wang WX, Liu Y, Wu HF, Chen C et al.. Dexmedetomidine increases acetylation level of histone through ERK1/2 pathway in dopamine neuron. Human & experimental toxicology 2017. link 31 Tomazi L, Mello CF, Schöffer AP, Girardi BA, Frühauf PKS, Rubin MA. A Nonrewarding NMDA Receptor Antagonist Impairs the Acquisition, Consolidation, and Expression of Morphine Conditioned Place Preference in Mice. Molecular neurobiology 2017. link 32 Yamamotová A, Fricová J, Rokyta R, Šlamberová R. The effect of combined treatment of opioids with methylphenidate on nociception in rats and pain in human. Physiological research 2016. link 33 Baharlouei N, Sarihi A, Komaki A, Shahidi S, Haghparast A. Blockage of acquisition and expression of morphine-induced conditioned place preference in rats due to activation of glutamate receptors type II/III in nucleus accumbens. Pharmacology, biochemistry, and behavior 2015. link 34 Reisi Z, Bani-Ardalan M, Zarepour L, Haghparast A. Involvement of D1/D2 dopamine receptors within the nucleus accumbens and ventral tegmental area in the development of sensitization to antinociceptive effect of morphine. Pharmacology, biochemistry, and behavior 2014. link 35 Wu H, Baynes RE, Leavens T, Tell LA, Riviere JE. Use of population pharmacokinetic modeling and Monte Carlo simulation to capture individual animal variability in the prediction of flunixin withdrawal times in cattle. Journal of veterinary pharmacology and therapeutics 2013. link 36 Chen F, Li S, Li D, Ding JS. Transdermal behaviors comparisons among Evodia rutaecarpa extracts with different purity of evodiamine and rutaecarpine and the effect of topical formulation in vivo. Fitoterapia 2012. link 37 Baba Y, Kohase H, Oono Y, Fujii-Abe K, Arendt-Nielsen L. Effects of dexmedetomidine on conditioned pain modulation in humans. European journal of pain (London, England) 2012. link 38 Mariani RK, Mello CF, Rosa MM, Ceretta AP, Camera K, Rubin MA. Effect of naloxone and morphine on arcaine-induced state-dependent memory in rats. Psychopharmacology 2011. link 39 González-Cuello A, Mora L, Hidalgo JM, Meca N, Lasheras C, Milanés MV et al.. Enhanced tyrosine hydroxylase phosphorylation in the nucleus accumbens and nucleus tractus solitarius-A2 cell group after morphine-conditioned place preference. Naunyn-Schmiedeberg's archives of pharmacology 2010. link 40 Ogungbenro K, Aarons L. Sample size/power calculations for repeated ordinal measurements in population pharmacodynamic experiments. Journal of pharmacokinetics and pharmacodynamics 2010. link 41 Jones P, Griffin AM, Gawell L, Lavoie R, Delorme D, Roberts E et al.. N,N-Diethyl-4-[(3-hydroxyphenyl)(piperidin-4-yl)amino] benzamide derivatives: the development of diaryl amino piperidines as potent delta opioid receptor agonists with in vivo anti-nociceptive activity in rodent models. Bioorganic & medicinal chemistry letters 2009. link 42 Cyr MC, Morgan MM. Early methylphenidate exposure enhances morphine antinociception and tolerance in adult rats. Neuropharmacology 2009. link 43 Ma YY, Meng L, Guo CY, Han JS, Lee DY, Cui CL. Dose- and time-dependent, context-induced elevation of dopamine and its metabolites in the nucleus accumbens of morphine-induced CPP rats. Behavioural brain research 2009. link 44 Van Soens I, Struys MM, Polis IE, Tshamala M, Nollet H, Bhatti SF et al.. Effects of sedative and hypnotic drug combinations on transcranial magnetic motor evoked potential, bispectral index and ARX-derived auditory evoked potential index in dogs. Veterinary journal (London, England : 1997) 2009. link 45 Maleki SA, Samini M, Babapour V, Mehr SE, Cheraghiyan S, Nouri MH. Potentiation of morphine-induced conditioned place preference with concurrent use of amantadine and fluvoxamine by the intraperitoneal and intracerebroventricular injection in rat. Behavioural brain research 2008. link 46 Ganesh A, Gonzalez-Sulser A, Chaijale N, Cucchiaro G. Electrophysiologic effects of systemic and locally infused epibatidine on locus coeruleus neurons. European journal of pharmacology 2008. link 47 Hiebel AC, Lee YS, Bilsky E, Giuvelis D, Deschamps JR, Parrish DA et al.. Probes for narcotic receptor mediated phenomena. 34. Synthesis and structure-activity relationships of a potent mu-agonist delta-antagonist and an exceedingly potent antinociceptive in the enantiomeric C9-substituted 5-(3-hydroxyphenyl)-N-phenylethylmorphan series. Journal of medicinal chemistry 2007. link 48 Walker BM, Ettenberg A. Intracerebroventricular ethanol-induced conditioned place preferences are prevented by fluphenazine infusions into the nucleus accumbens of rats. Behavioral neuroscience 2007. link 49 Gong YX, Lv M, Zhu YP, Zhu YY, Wei EQ, Shi H et al.. Endogenous histamine inhibits the development of morphine-induced conditioned place preference. Acta pharmacologica Sinica 2007. link 50 Yim AJ, Moraes CR, Ferreira TL, Oliveira MG. Protein synthesis inhibition in the basolateral amygdala following retrieval does not impair expression of morphine-associated conditioned place preference. Behavioural brain research 2006. link 51 Noh GJ, Kim KM, Jeong YB, Jeong SW, Yoon HS, Jeong SM et al.. Electroencephalographic approximate entropy changes in healthy volunteers during remifentanil infusion. Anesthesiology 2006. link 52 Yonghui L, Xigeng Z, Yunjing B, Xiaoyan Y, Nan S. Opposite effects of MK-801 on the expression of food and morphine-induced conditioned place preference in rats. Journal of psychopharmacology (Oxford, England) 2006. link 53 Jafari-Sabet M, Zarrindast MR, Rezayat M, Rezayof A, Djahanguiri B. The influence of NMDA receptor agonist and antagonist on morphine state-dependent memory of passive avoidance in mice. Life sciences 2005. link 54 Do Ribeiro Couto B, Aguilar MA, Rodríguez-Arias M, Miñarro J. Cross-reinstatement by cocaine and amphetamine of morphine-induced place preference in mice. Behavioural pharmacology 2005. link 55 Orsini C, Bonito-Oliva A, Conversi D, Cabib S. Susceptibility to conditioned place preference induced by addictive drugs in mice of the C57BL/6 and DBA/2 inbred strains. Psychopharmacology 2005. link 56 Sanders RD, Giombini M, Ma D, Ohashi Y, Hossain M, Fujinaga M et al.. Dexmedetomidine exerts dose-dependent age-independent antinociception but age-dependent hypnosis in Fischer rats. Anesthesia and analgesia 2005. link 57 Zarrindast MR, Nasehi M, Rostami P, Rezayof A, Fazli-Tabaei S. Repeated administration of dopaminergic agents in the dorsal hippocampus and morphine-induced place preference. Behavioural pharmacology 2005. link 58 Cortinez LI, Hsu YW, Sum-Ping ST, Young C, Keifer JC, Macleod D et al.. Dexmedetomidine pharmacodynamics: Part II: Crossover comparison of the analgesic effect of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology 2004. link 59 Angst MS, Ramaswamy B, Davies MF, Maze M. Comparative analgesic and mental effects of increasing plasma concentrations of dexmedetomidine and alfentanil in humans. Anesthesiology 2004. link 60 Zarrindast MR, Jafari MR, Ahmadi S, Djahanguiri B. Influence of central administration ATP-dependent K+ channel on morphine state-dependent memory of passive avoidance. European journal of pharmacology 2004. link 61 Kratzer U, Spanagel R, Schmidt WJ. The effect of acamprosate on the development of morphine-induced behavioral sensitization in rats. Behavioural pharmacology 2003. link 62 McGeehan AJ, Olive MF. The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse. Synapse (New York, N.Y.) 2003. link 63 Lieving LM, Odum AL, Schaal DW. The effects of morphine on chained and clocked fixed-interval schedule performance in pigeons. Behavioural pharmacology 2002. link 64 Li M, McMillan DE. Four-choice drug discrimination in pigeons. Behavioural pharmacology 2001. link 65 Allen RM, Dykstra LA. N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys. The Journal of pharmacology and experimental therapeutics 2001. link 66 McMillan DE, Li M, Hardwick WC. Schedule control of quantal and graded dose-effect curves in a drug-drug-saline discrimination. Pharmacology, biochemistry, and behavior 2001. link00474-3) 67 Chen JC, Liang KW, Huang EY. Differential effects of endomorphin-1 and -2 on amphetamine sensitization: neurochemical and behavioral aspects. Synapse (New York, N.Y.) 2001. link39:3<239::AID-SYN1005>3.0.CO;2-B) 68 Suzuki T, Shimizu R, Suganuma T, Nishino J, Tomono K, Hanano M et al.. Pharmacokinetic/pharmacodynamic relationship of eptazocine, a narcotic-antagonist analgesic, in rats. Biological & pharmaceutical bulletin 2000. link 69 Bartoletti M, Gubellini C, Gaiardi M. Sensitization to the morphine-like discriminative stimulus effects of buprenorphine in rats. Pharmacological research 2000. link 70 Hutcheson DM, Subhan F, Pache DM, Maldonado R, Fournié-Zaluski M, Roques BP et al.. Analgesic doses of the enkephalin degrading enzyme inhibitor RB 120 do not have discriminative stimulus properties. European journal of pharmacology 2000. link00441-6) 71 Tzchentke TM, Schmidt WJ. Effects of the non-competitive NMDA-receptor antagonist memantine on morphine- and cocaine-induced potentiation of lateral hypothalamic brain stimulation reward. Psychopharmacology 2000. link 72 Logman MJ, Budygin EA, Gainetdinov RR, Wightman RM. Quantitation of in vivo measurements with carbon fiber microelectrodes. Journal of neuroscience methods 2000. link00155-7) 73 Cox EH, Langemeijer MW, Gubbens-Stibbe JM, Muir KT, Danhof M. The comparative pharmacodynamics of remifentanil and its metabolite, GR90291, in a rat electroencephalographic model. Anesthesiology 1999. link 74 McMillan DE, Li M. Effects of drugs on responding under concurrent fixed-interval schedules and concurrent fixed-ratio schedules. Behavioural pharmacology 1999. link 75 Semenova S, Danysz W, Bespalov A. Low-affinity NMDA receptor channel blockers inhibit acquisition of intravenous morphine self-administration in naive mice. European journal of pharmacology 1999. link00431-8) 76 Tzschentke TM, Schmidt WJ. Discrete quinolinic acid lesions of the rat prelimbic medial prefrontal cortex affect cocaine- and MK-801-, but not morphine- and amphetamine-induced reward and psychomotor activation as measured with the place preference conditioning paradigm. Behavioural brain research 1998. link00034-5) 77 Gaiardi M, Bartoletti M, Gubellini C. Facilitatory and inhibitory actions of morphine on the discriminative stimulus properties of D-amphetamine. Pharmacological research 1998. link 78 Stafford D, LeSage MG, Glowa JR. Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: a review. Psychopharmacology 1998. link 79 Cook CD, Picker MJ. Dopaminergic activity and the discriminative stimulus effects of mu opioids in pigeons: importance of training dose and attenuation by the D3 agonist (+/-)-7-OH-DPAT. Psychopharmacology 1998. link 80 Epping-Jordan MP, Markou A, Koob GF. The dopamine D-1 receptor antagonist SCH 23390 injected into the dorsolateral bed nucleus of the stria terminalis decreased cocaine reinforcement in the rat. Brain research 1998. link01190-6) 81 Ukai M, Mori E, Kameyama T. Modulatory effects of morphine, U-50488H and 1,3-di-(2-tolyl)guanidine on cocaine-like discriminative stimulus in the rat using two-choice discrete-trial avoidance paradigm. Methods and findings in experimental and clinical pharmacology 1997. link 82 Swahn BM, Edvinsson KM, Kallin E, Larsson U, Berge OG, Molin H et al.. Two non-racemic preparations of a piperidine-based NMDA antagonist with analgesic activity. Bioorganic & medicinal chemistry 1997. link00057-6) 83 Upton RN, Ludbrook GL, Gray EC, Grant C. The cerebral pharmacokinetics of meperidine and alfentanil in conscious sheep. Anesthesiology 1997. link 84 Tzschentke TM, Schmidt WJ. Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization. Behavioural brain research 1997. link83329-3) 85 Biała G, Langwiński R. Rewarding properties of some drugs studied by place preference conditioning. Polish journal of pharmacology 1996. link 86 Vercauteren MP, Saldien V, Bosschaerts P, Adriaensen HA. Potentiation of sufentanil by clonidine in PCEA with or without basal infusion. European journal of anaesthesiology 1996. link 87 Bell K, Kalivas PW. Context-specific cross-sensitization between systemic cocaine and intra-accumbens AMPA infusion in the rat. Psychopharmacology 1996. link 88 Izenwasser S, Newman AH, Cox BM, Katz JL. The cocaine-like behavioral effects of meperidine are mediated by activity at the dopamine transporter. European journal of pharmacology 1996. link00696-6) 89 Damaj MI, Martin BR. Tolerance to the antinociceptive effect of epibatidine after acute and chronic administration in mice. European journal of pharmacology 1996. link00834-9) 90 McGaraughty S, Reinis S, Tsoukatos J. A correlogram analysis of the activity in the rostral ventromedial medulla of awake rats and in rats anesthetized with ketamine or pentobarbital following the administration of morphine. Experimental brain research 1995. link 91 Mandema JW, Wada DR. Pharmacodynamic model for acute tolerance development to the electroencephalographic effects of alfentanil in the rat. The Journal of pharmacology and experimental therapeutics 1995. link 92 Yee JD, Berde CB. Dextroamphetamine or methylphenidate as adjuvants to opioid analgesia for adolescents with cancer. Journal of pain and symptom management 1994. link90165-1) 93 Sainsbury RS, Partlo LA. Alpha 2 modulation of type 1 and type 2 hippocampal theta in the freely moving rat. Brain research bulletin 1993. link90238-7) 94 Winger G, Skjoldager P, Woods JH. Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys. The Journal of pharmacology and experimental therapeutics 1992. link 95 Noble F, Soleilhac JM, Soroca-Lucas E, Turcaud S, Fournie-Zaluski MC, Roques BP. Inhibition of the enkephalin-metabolizing enzymes by the first systemically active mixed inhibitor prodrug RB 101 induces potent analgesic responses in mice and rats. The Journal of pharmacology and experimental therapeutics 1992. link 96 Cunningham ST, Kelley AE. Evidence for opiate-dopamine cross-sensitization in nucleus accumbens: studies of conditioned reward. Brain research bulletin 1992. link90137-m) 97 Ranise A, Bondavalli F, Bruno O, Schenone S, D'Amico M, Parrillo C et al.. omega-Dialkylaminoalkyl esters of N-phenyl aminethiocarboximidic acids with local anesthetic and other activities. Farmaco (Societa chimica italiana : 1989) 1992. link 98 Dambisya YM, Chan K, Wong CL. Role of adrenoceptors in the potentiation of opioid antinociception by ephedrine and phenylpropanolamine in mice. Psychopharmacology 1991. link 99 Bilsky EJ, Marglin SH, Reid LD. Using antagonists to assess neurochemical coding of a drug's ability to establish a conditioned place preference. Pharmacology, biochemistry, and behavior 1990. link90007-5) 100 Bloss JL, Hammond DL. Intermittent shock titration task in the rhesus monkey and its validity as an analgesiometric procedure. Brain research 1989. link90783-x)